Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration.
Charles C WykoffPeter A CampochiaroDante J PieramiciArshad M KhananiShamika GuneMauricio MaiaMatts KågedalHan Ting DingKatie F MaassPublished in: Ophthalmology and therapy (2022)
ClinicalTrials.gov identifier, NCT02510794.